The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Open accessAbstract
Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As an example, the most common Cas9 system, SpCas9, recognises NGG motifs and therefore only sequences adjacent to that motif can be targeted [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR systems might be an alternative or a tool to use together with conventional antibiotics, either by disabling antibiotic-resistance genes or by developing toxicity in bacteria through the cleavage of crucial domains of their genome, exerting a bactericidal effect [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In early 2013, Jiang et al. used the CRISPR-Cas9 system to induce targeted mutations (insertions, deletions, and single-nucleotide substitutions) in the genome of Streptococcus pneumoniae and E. coli strains [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
In the citing paper
“The type II CRISPR/Cas9 system has been exploited for high-efficiency gene editing in model microorganisms such as E. coli (Jiang et al., 2015), S. cerevisiae (DiCarlo et al., 2013), and Streptococcus pneumoniae (Jiang et al., 2013).”
From Gas Fermentation—A Flexible Platform for Commercial Scale Production of Low-Carbon-Fuels and Chemicals from Waste and Renewable Feedstocks (2016) · cites this paper as Jiang et al., 2013
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [93]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationEnzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 10,088
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus
Deveau, H., Barrangou, R., Garneau, J. E., Labonté, J., Fremaux, C., Boyaval, P., Romero, D. A., Horvath, P., & Moineau, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.01412-07 · Cited by 1,196
Haft, D. H., Selengut, J., Mongodin, E. F., & Nelson, K. E. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010060 · Cited by 1,014
TAL effectors: customizable proteins for DNA targeting
Bogdanove, A. J., & Voytas, D. F. (2011) · Science · doi:10.1126/science.1204094 · Cited by 984
Grissa, I., Vergnaud, G., & Pourcel, C. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-172 · Cited by 888
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
Sapranauskas, R., Gasiūnas, G., Fremaux, C., Barrangou, R., Horvath, P., & Šikšnys, V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr606 · Cited by 835
Recombineering: a homologous recombination-based method of genetic engineering
Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., & Court, D. L. (2009) · Nature Protocols · doi:10.1038/nprot.2008.227 · Cited by 808
Håvarstein, L. S., Coomaraswamy, G., & Morrison, D. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11140 · Cited by 748
Horinouchi, S., & Weisblum, B. (1982) · Journal of Bacteriology · doi:10.1128/jb.150.2.815-825.1982 · Cited by 738
Semenova, E., Jore, M. M., Datsenko, K. A., Semenova, A., Westra, E. R., Wanner, B., van der Oost, J., Brouns, S. J. J., & Severinov, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104144108 · Cited by 726
Genome of the Bacterium Streptococcus pneumoniae Strain R6
Hoskins, J., Alborn, W. E., Arnold, J. S., Blaszczak, L. C., Burgett, S. G., DeHoff, B. S., Estrem, S. T., Fritz, L. A., Fu, D., Fuller, W., et al. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.19.5709-5717.2001 · Cited by 721
Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease
Haurwitz, R. E., Jínek, M., Wiedenheft, B., Zhou, K., & Doudna, J. A. (2010) · Science · doi:10.1126/science.1192272 · Cited by 710
Sortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria
Marraffini, L. A., DeDent, A. C., & Schneewind, O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.192-221.2006 · Cited by 688
Self versus non-self discrimination during CRISPR RNA-directed immunity
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature · doi:10.1038/nature08703 · Cited by 642
Allelic replacement in Staphylococcus aureus with inducible counter-selection
Bae, T., & Schneewind, O. (2005) · Plasmid · doi:10.1016/j.plasmid.2005.05.005 · Cited by 624
CRISPR/Cas System and Its Role in Phage-Bacteria Interactions
Deveau, H., Garneau, J. E., & Moineau, S. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134123 · Cited by 624
Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotesPreprint
Carte, J. M., Wang, R., Li, H., Terns, R. M., & Terns, M. P. (2008) · Genes & Development · doi:10.1101/gad.1742908 · Cited by 568
CRISPR-based adaptive and heritable immunity in prokaryotes
John van der, O. O. S. T., Jore, M. M., Westra, E. R., Lundgren, M., & Brouns, S. J. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.05.002 · Cited by 524
Makarova, K. S., Aravind, L., Wolf, Y. I., & Koonin, E. V. (2011) · Biology Direct · doi:10.1186/1745-6150-6-38 · Cited by 484
Homing endonuclease structure and function
Stoddard, B. L. (2005) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583505004063 · Cited by 464
CRISPR-based adaptive immune systems
Terns, M. P., & Terns, R. M. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.03.005 · Cited by 461
Wiedenheft, B., van Duijn, E., Bultema, J. B., Waghmare, S. P., Zhou, K., Barendregt, A., Westphal, W., Heck, A. J. R., Boekema, E. J., Dickman, M. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102716108 · Cited by 449
Evolutionary conservation of sequence and secondary structures in CRISPR repeats
Kunin, V., Sorek, R., & Hugenholtz, P. (2007) · Genome biology · doi:10.1186/gb-2007-8-4-r61 · Cited by 449
An rpsL Cassette, Janus, for Gene Replacement through Negative Selection in Streptococcus pneumoniae
Sung, C. K., Li, H., Claverys, J., & Morrison, D. A. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.11.5190-5196.2001 · Cited by 405
Bikard, D., Hatoum-Aslan, A., Mucida, D., & Marraffini, L. A. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.003 · Cited by 322
Enhanced levels of λ Red-mediated recombinants in mismatch repair mutants
Costantino, N., & Court, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434959100 · Cited by 275
Genome-scale promoter engineering by coselection MAGE
Wang, H. H., Kim, H., Cong, L., Jeong, J., Bang, D., & Church, G. M. (2012) · Nature Methods · doi:10.1038/nmeth.1971 · Cited by 230
Gudbergsdóttir, S. R., Deng, L., Chen, Z., Jensen, J. V. K., Jensen, L. R., She, Q., & Garrett, R. A. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07452.x · Cited by 228
Podbielski, A., Spellerberg, B., Woischnik, M., Pohl, B., & Lütticken, R. (1996) · Gene · doi:10.1016/0378-1119(96)84178-3 · Cited by 197
In Vitro Recombination and Mutagenesis of DNA: SOEing Together Tailor-Made Genes
Horton, R. M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-244-2:251 · Cited by 196
Hatoum-Aslan, A., Maniv, I., & Marraffini, L. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112832108 · Cited by 185
The Escherichia coli CRISPR System Protects from λ Lysogenization, Lysogens, and Prophage Induction
Edgar, R., & Qimron, U. (2010) · Journal of Bacteriology · doi:10.1128/jb.00644-10 · Cited by 165
Fischer, S. M., Maier, L., Stoll, B., Brendel, J., Fischer, E., Pfeiffer, F., Dyall‐Smith, M., & Marchfelder, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377002 · Cited by 130
The Streptococcus pneumoniae Beta-Galactosidase Is a Surface Protein
Zähner, D., & Hakenbeck, R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.20.5919-5921.2000 · Cited by 87
Husmann, L. K., Scott, J. R., Lindahl, G., & Stenberg, L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.345-348.1995 · Cited by 85
Motamedi, M. R., Szigety, S. K., & Rosenberg, S. M. (1999) · Genes & Development · doi:10.1101/gad.13.21.2889 · Cited by 77
A CRISPR Approach to Gene Targeting
Carroll, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.171 · Cited by 66
RNA-mediated programmable DNA cleavage
Barrangou, R. (2012) · Nature Biotechnology · doi:10.1038/nbt.2357 · Cited by 59
Hosaka, T., Tamehiro, N., Chumpolkulwong, N., Hori-Takemoto, C., Shirouzu, M., Yokoyama, S., & Ochi, K. (2004) · Molecular Genetics and Genomics · doi:10.1007/s00438-004-0982-z · Cited by 37
A Swiss Army Knife of Immunity
Brouns, S. J. J. (2012) · Science · doi:10.1126/science.1227253 · Cited by 12
Flagged first, then by citations
Cited by
Sorted by citations
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Self-citationDevelopment and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
“While our paper was under review, several very recent studies reported the use of wild-type Cas9/CRISPR for targeted genome editing in diverse organisms (Mali et al., 2013; Cong et al., 2013; Jinek et al., 2013; Jiang et al., 2013; Hwang et al., 2013; Cho et al., 2013).”
BackgroundCpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Self-citation
Metadata
- Authors
- Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A.
- Affiliations
- Rockefeller University (US)
- Broad Institute (US)
- Corresponding author
- Bikard, David
- Marraffini, Luciano A
- Venue
- Nature Biotechnology
- Published
- 2013-01-29
- Volume
- 31
- Issue
- 3
- Pages
- 233-239
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3748948
- OpenAlex
- W2000046950
- Cited by
- 2,429
- References
- 51
- Citations by year
- 2026: 84 · 2025: 124 · 2024: 151 · 2023: 162 · 2022: 199 · 2021: 203 · 2020: 245 · 2019: 185 · 2018: 206 · 2017: 208 · 2016: 203 · 2015: 174 · 2014: 183 · 2013: 98
- FWCI
- 98.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- U.S. Public Health Service
- National Institute of Mental Health (DP1MH100706)
- National Institute of General Medical Sciences (T32GM007753)
- National Institute of Allergy and Infectious Diseases (DP2AI104556)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, bacterial genome editing, Streptococcus pneumoniae, Escherichia coli, targeted mutagenesis, recombineering, genome editing
- MeSH terms
- Base Sequence, Endonucleases, Escherichia coli, Genetic Engineering, Molecular Sequence Data, Streptococcus pneumoniae, Mutagenesis, Site-Directed, Genome, Bacterial, DNA Cleavage, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
